Headaches, including those persisting beyond 3 months, affect 37%-46% of patients after hemorrhagic stroke, new research suggests.

Now, with the European Union Health Technology Assessment (HTA) regulation coming into force as part of the required Joint Clinical Assessment (JCA) for oncology and advanced therapy medicinal ...

Background In 2024, the UK National Institute of Health and Care Excellence (NICE) recommended TriageHF alerts as an option ...

Background Malnutrition influences prognosis in patients with heart failure, but current nutritional evaluation methods are ...

Objective This study aimed to evaluate the prevalence and predictors of cardiovascular disease (CVD), chronic kidney disease ...

Objectives To analyse the impact on SARS-CoV-2 transmission of tier 3 restrictions introduced in October and December 2020 in England, compared with tier 2 restrictions. We further investigate whether ...

So far this year, at least four states have redrawn their congressional districts with the stated goal of advantaging one party or the other in the 2026 midterms. Several others are exploring similar ...

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

Galectin Therapeutics Inc. is rated a Hold due to absence of finalized agreement with FDA, combined with a tight runway. Read ...

Gordon Scott has been an active investor and technical analyst or 20+ years. He is a Chartered Market Technician (CMT). Thomas J Catalano is a CFP and Registered Investment Adviser with the state of ...

Biohaven said on Wednesday its experimental depression drug did not meet the main goal of a ​mid-stage trial, adding to a string of trial and regulatory ‌setbacks for the drugmaker this year. The ...

Oncolytics Biotech® Inc. (Nasdaq: ONCY) ("Oncolytics" or the "Company"), a clinical-stage immunotherapy company developing pelareorep, today announced clinical and translational findings supporting ...